Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Applied Therapeutics, Inc. APLT | Perceptive Advisors LLC | 10,005,000 8.500% | 5,424,751 (+118.44%) | Filing History |
| 2024-11-14 4:50 pm Sale | 2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX | Perceptive Advisors LLC | 0 0.000% | -4,776,306 (Position Closed) | Filing History |
| 2024-11-14 4:41 pm Unchanged | 2024-11-14 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 6,485,420 11.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:33 pm Purchase | 2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE | Perceptive Advisors LLC | 2,872,547 5.700% | 265,868 (+10.20%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 151,433 9.990% | 151,433 (New Position) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Arcellx, Inc. ACLX | Perceptive Advisors LLC | 3,888,669 7.200% | -656,140 (-14.44%) | Filing History |
| 2024-11-14 4:31 pm Unchanged | 2024-11-14 | 13D | Nautilus Biotechnology, Inc. NAUT | Perceptive Advisors LLC | 12,594,211 10.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-08-07 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 3,454,976 8.800% | 380,434 (+12.37%) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Adagio Medical Holdings, Inc. ADGM | Perceptive Advisors LLC | 15,257,488 76.400% | 15,257,488 (New Position) | Filing History |
| 2024-10-31 4:16 pm Purchase | 2024-10-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 547,935 14.200% | 2,090 (+0.38%) | Filing History |
| 2024-10-29 5:27 pm Purchase | 2024-10-22 | 13G | Ensysce Biosciences, Inc. ENSC | Perceptive Advisors LLC | 86,667 8.700% | 86,667 (New Position) | Filing History |
| 2024-10-25 5:38 pm Purchase | 2024-10-18 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Perceptive Advisors LLC | 4,458,741 6.500% | 2,589,616 (+138.55%) | Filing History |
| 2024-10-22 4:15 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | Perceptive Advisors LLC | 6,799,944 9.990% | 6,799,944 (New Position) | Filing History |
| 2024-10-17 4:15 pm Purchase | 2024-10-15 | 13D | Immatics N.V. IMTX | Perceptive Advisors LLC | 9,469,705 7.900% | 1,298,859 (+15.90%) | Filing History |
| 2024-10-16 1:14 pm Purchase | 2024-10-14 | 13G | Bright Minds Biosciences Inc. DRUG | Perceptive Advisors LLC | 430,000 9.600% | 430,000 (New Position) | Filing History |
| 2024-10-10 6:57 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Perceptive Advisors LLC | 1,004,439 7.900% | 1,004,439 (New Position) | Filing History |
| 2024-09-27 4:16 pm Purchase | 2024-09-17 | 13G | Instil Bio, Inc. TIL | Perceptive Advisors LLC | 345,545 5.300% | 345,545 (New Position) | Filing History |
| 2024-09-24 7:04 pm Sale | 2024-09-20 | 13D | Vapotherm, Inc. VAPO | Perceptive Advisors LLC | 1,000 100.000% | -2,011,999 (-99.95%) | Filing History |
| 2024-09-23 5:42 pm Purchase | 2024-09-12 | 13G | Praxis Precision Medicines, Inc. PRAX | Perceptive Advisors LLC | 1,119,035 6.300% | 1,119,035 (New Position) | Filing History |
| 2024-08-15 6:31 pm Sale | 2024-08-14 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 255,151 19.500% | -0 (-0.00%) | Filing History |